Project Grant HT94252411047
Award Date
12/1/24
Completion Date
11/30/27
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $855,728 to The Johns Hopkins University to identify abnormally regulated lipid pathways in human motor neuron and fly models, with the goal of developing a new pharmacological drug candidate. The award period runs from Sep 1, 2024 to Aug 31, 2026. As a leading research university, Johns Hopkins has a strong track record of federal grant...
The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and...
The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
The U.S. Defense Health Agency awarded a $621,011 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The grant, with a performance period from July 1, 2025 to June 30, 2027, will fund research targeting sensory neurons via anti-CGRP therapies in osteosarcoma. As a leading federal contractor and grantee, The Johns Hopkins University has demonstrated extensive capabilities in advanced biomedical research across diverse medical...
The Department of Defense's Defense Health Agency awarded a $318,483 Project Grant to The Johns Hopkins University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used for a 2-year project to quantitatively measure acute and chronic lesion activity in a real-world, multi-site clinical MRI...
The Johns Hopkins University will receive $966,758 under a Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered under Assistance Listing Number 12.420. Under this three-year award ending in August 2025, The Johns Hopkins University will investigate circulating central nervous system cell-derived extracellular vesicle based biomarkers to identify neurodegeneration and glial activation in...
The federal Project Grant award of $465,568.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The Johns Hopkins University on the role of epitranscriptomic modulators in response to bipolar androgen therapy. The award period runs from September 15, 2025 to September 14, 2027 and aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research. As a leading...
This federal Project Grant award of $814,065 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research into the "MECHANISMS OF IRISIN-INDUCED COGNITIVE BENEFIT IN PD" at The Johns Hopkins University. The 2-year grant, awarded on December 1, 2024 with a completion date of November 30, 2026, will fund sophisticated biomedical research and analysis to explore innovative approaches for addressing Parkinson's Disease. As a...
The Department of Defense's Defense Health Agency awarded a $319,240 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The grant, awarded on September 1, 2025, will fund research to characterize microRNAs involved in regulating human oligodendrocyte maturation and myelin formation. This research, to be conducted over 2 years until August 31, 2027, aims to transform healthcare for military service members, veterans, and the...
The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....